Dichloroacetate, a potent PDK inhibitor, effectively inhibits TGF-β-mediated myofibroblast differentiation in vitro and induces pulmonary fibrosis in vivo, causing altered fibroblast metabolism (Goodwin et al., 2018). This evidence concerns the gene TGFB1 and pulmonary fibrosis.